Mr. Shahab Samimi reports

HUMANOID GLOBAL ANNOUNCES CLOSING OF SPECIAL WARRANT FINANCING

Further to the news release of Oct. 14, 2025, Humanoid Global Holdings Corp. has completed its previously announced non-brokered private placement of special warrants at a price of 80 cents per special warrant. The company issued 2.5 million special warrants at a price of 80 cents per special warrant for gross proceeds of $2-million.

Each special warrant will automatically convert into one common share of the company and one transferable common share purchase warrant. Each warrant will entitle the holder to acquire one share at a price of $1.20 per share for a period of 24 months following the date of issuance of the special warrants.

Each special warrant will automatically convert, for no additional consideration, into one share and one warrant on the earlier of: (i) the date that is three business days following the date on which the company files a prospectus supplement to a short form base shelf prospectus with the applicable securities commissions qualifying the distribution of the units underlying the special warrants; and (ii) the date that is four months and one day after the closing of the offering.

The filing of a prospectus supplement will be at the sole discretion of the company, and the company is under no obligation to file a prospectus supplement or qualify the distribution of the shares and warrants underlying the special warrants. The company may, at its discretion, determine not to proceed with the filing of a prospectus supplement, in which case the special warrants will automatically convert into shares and warrants following the expiry of the statutory four-month hold period.

In connection with the offering, the company paid finders' fees to eligible finders consisting of $133,000 in cash and 166,250 common share purchase warrants. Each finder's warrant is exercisable for one share at a price of $1.20 per share for a period of 24 months following the date of issuance.

All securities issued in connection with the offering are subject to a statutory hold period of four months plus a day in accordance with applicable securities legislation and policies of the Canadian Securities Exchange ending on Feb. 25, 2026.

The company will use the net proceeds of the offering for general working capital purposes. In parallel with the offering, during the current year, the company has realized gross proceeds of $74,425 from the sale of certain investments. In addition, ahead of the offering's closing, a number of previously issued warrants were exercised, providing $229,710 in additional cash proceeds to the company. Humanoid Global has received a demand letter from its former chief executive officer, which is currently under review. At this time, no legal proceedings have been commenced. The company believes the allegations are without merit. Management remains confident in the company's strategic direction, and continues to advance its operations and growth initiatives without interruption.

About Humanoid Global Holdings Corp.

Humanoid is a publicly traded investment issuer building a portfolio of pioneering companies in the growing humanoid robotics and embodied artificial intelligence sector, investing in and accelerating their growth. It serves as a global investment platform providing liquidity and access to an actively managed portfolio spanning the value chain of this emerging ecosystem, including advanced software, hardware and enabling technologies. Led by a team with a proven record of scaling transformative technologies globally, the company takes a long-term, partnership-oriented approach. It provides capital and strategic consultation on go-to-market strategies, regulatory pathways and transaction advisory while facilitating introductions to customers, suppliers and strategic partners.

We seek Safe Harbor.